Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019

ウイルス性肝炎/レトロウイルス検査の世界市場2015-2019

◆タイトル:Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019
◆商品コード:IRTNTR7415
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年10月21日
◆ページ数:85
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ウイルス性肝炎/レトロウイルス検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ウイルス性肝炎/レトロウイルス検査の世界市場規模及び予測、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About viral hepatitis and retrovirus diagnostic tests
Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.

Technavio’s analysts forecast the global viral hepatitis and retrovirus diagnostic tests market to grow at a CAGR of 10.83% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the global viral hepatitis and retrovirus diagnostic tests market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of assays and instruments for diagnostic testing of viral hepatitis and retrovirus.

Technavio’s report, Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• APAC
• Europe
• Latin America
• MEA
• North America

[Key vendors]
• Abbott Diagnostics
• Alere
• Chembio
• DiaSorin
• Roche Diagnostics

[Other prominent vendors]
• Amkay Products
• AOV International
• Apothecaries Sundries Manufacturing
• Beckman Coulter
• Becton Dickinson
• Bhat Bio-tech
• bioMerieux
• Bioneovan
• Bio-Rad
• Cepheid
• Enzo Biochem
• Fujirebio
• Gemc Technology (Zhengzhou)
• Grifols
• Hangzhou Deangel Biological Engineering
• Hangzhou Heo Bio-Tech
• Hologic
• Horiba
• Innovation Biotech (Beijing)
• Jaksh Enterprises
• Krishco Medical Products
• Micro Sidd
• Nantong Egens Biotechnology
• Nexus Lifecare
• Ortho-Clinical Diagnostics
• Qiagen
• Qingdao Hightop Biotech
• Scienion
• SeraCare
• Shanghai Kehua Bio-engineering
• Siemens Healthcare Diagnostics
• Span Diagnostics
• Synergy Healthcare
• Thermo Fisher Scientific
• Transasia Bio-Medicals
• Wako
• YVR Medivision
• Zhuhai Encode Medical Engineering

[Market driver]
• High prevalence and awareness of HIV and hepatitis
• For a full, detailed list, view our report

[Market challenge]
• Limitation of closed system
• For a full, detailed list, view our report

[Market trend]
• Increased usage of POC diagnostic tests
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Overview
Hepatitis
HIV

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Geographical segmentation
Global viral hepatitis and retrovirus diagnostic tests market by geographical segmentation
Viral hepatitis and retrovirus diagnostic tests market in Americas
Viral hepatitis and retrovirus diagnostic tests market in EMEA
Viral hepatitis and retrovirus diagnostic tests market in APAC

PART 08: Key focus countries
Brazil
China

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 15: Key vendor analysis
Abbott Diagnostics
Alere
Chembio
DiaSorin
Roche Diagnostics

PART 16: Appendix
List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global endemicity of hepatitis A infection
Exhibit 03: Endemicity pattern of hepatitis B across different regions
Exhibit 04: Prevalence rates of hepatitis B in APAC
Exhibit 05: Acute hepatitis B infection by age groups (2005-2013)
Exhibit 06: Chronic hepatitis B infection by age groups (2005-2013)
Exhibit 07: Prevalence of hepatitis B in US (2005-2013)
Exhibit 08: Prevalence rates of hepatitis C across different geographies (2012)
Exhibit 09: Prevalence data of hepatitis C in APAC
Exhibit 10: Prevalence data of hepatitis C in Europe
Exhibit 11: Prevalence data of hepatitis C in Caribbean and Latin America
Exhibit 12: Prevalence data of hepatitis C in Middle-East and North Africa
Exhibit 13: Prevalence data of hepatitis C in North America
Exhibit 14: Prevalence data of hepatitis C in Sub-Saharan Africa
Exhibit 15: Medical cost for chronic viral hepatitis
Exhibit 16: Medical cost for treatment of hepatitis C-related infections
Exhibit 17: Demographic statistics for HIV (2014)
Exhibit 18: Low-cost portable tests for HIV diagnosis
Exhibit 19: Top 10 countries with highest number of healthcare facilities providing HIV testing in 2013
Exhibit 20: Global viral hepatitis and retrovirus diagnostic tests market
Exhibit 21: Global viral hepatitis and retrovirus diagnostic tests market 2014-2019 ($ millions)
Exhibit 22: Five forces analysis
Exhibit 23: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014
Exhibit 24: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2019
Exhibit 25: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014-2019
Exhibit 26: Viral hepatitis and retrovirus diagnostic tests market in Americas 2014-2019 ($ millions)
Exhibit 27: Viral hepatitis and retrovirus diagnostic tests market in EMEA 2014-2019 ($ millions)
Exhibit 28: Top countries in APAC with highest number of HIV patients (2012)
Exhibit 29: Viral hepatitis and retrovirus diagnostic tests market in APAC 2014-2019 ($ millions)
Exhibit 30: Viral hepatitis and retrovirus diagnostic tests market in Brazil 2014-2019 ($ millions)
Exhibit 31: Viral hepatitis and retrovirus diagnostic tests market in China 2014-2019 ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Abbott Diagnostics: Key takeaways
Exhibit 35: Alere: Key takeaways
Exhibit 36: Chembio: Key takeaways
Exhibit 37: DiaSorin: Key takeaways
Exhibit 38: Roche Diagnostics: Key takeaways
Exhibit 39: Abbott Diagnostics: Key business offerings
Exhibit 40: Alere: Business segmentation by revenue 2014
Exhibit 41: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 42: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 43: Chembio: Business segmentation by revenue 2014
Exhibit 44: Chembio: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 45: Chembio: Geographical segmentation by revenue 2014
Exhibit 46: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 47: DiaSorin: Geographical segmentation by revenue 2014



【掲載企業】

Abbott Diagnostics, Alere, Chembio, DiaSorin, Roche Diagnostics, Apothecaries Sundries Manufacturing, AOV International, Amkay Products, Beckman Coulter, Becton Dickinson, Bhat Bio-tech, Bioneovan, bioMerieux, Bio-Rad, Cepheid, Enzo Biochem, Fujirebio, Gemc Technology (Zhengzhou) Co, Grifols , Hangzhou Deangel Biological Engineering Co, Hologic, Hangzhou Heo Bio-Tech, Horiba, Innovation Biotech (Beijing) Co, Jaksh Enterprises, Krishco Medical Products, Micro Sidd, Nantong Egens Biotechnology Co, Nexus Lifecare, Ortho-Clinical Diagnostics, Qingdao Hightop Biotech Co, Qiagen, Scienion, SeraCare, Shanghai Kehua Bio-engineering, Span Diagnostics, Synergy Healthcare, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Transasia Bio-Medicals, Wako, YVR Medivision, Zhuhai Encode Medical Engineering.

【資料のキーワード】

ウイルス性肝炎検査、レトロウイルス検査、HIV、肝炎、診断装置、検査機器、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ウイルス性肝炎/レトロウイルス検査の世界市場2015-2019] (Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019 / IRTNTR7415)販売に関する免責事項
[ウイルス性肝炎/レトロウイルス検査の世界市場2015-2019] (Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019 / IRTNTR7415)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆